• Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with live biotherapeutics
• Phase I/II trial will run during 2022, with results expected in 2023
• Close to 15% of the Australian population suffer from insomnia, with sleep disorders costing the economy and society around $51 billion annually

SYD...